Cargando…

Hepatoprotective effect of Saccharomyces Cervisciae Cell Wall Extract against thioacetamide-induced liver fibrosis in rats

Fibrosis represents a common outcome of almost all chronic liver diseases and leads to an impairment of liver function that requires medical intervention. The current study aimed to evaluate the potential anti-fibrotic effect of Saccharomyces cervisciae cell wall extract (SCCWE) against thioacetamid...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Gendy, Zeinab A., El-Marasy, Salma A., Ahmed, Rania F., El-Batran, Seham A., Abd El-Rahman, Sahar S., Ramadan, A., Youssef, S.A.H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8203708/
https://www.ncbi.nlm.nih.gov/pubmed/34159266
http://dx.doi.org/10.1016/j.heliyon.2021.e07159
_version_ 1783708227572072448
author El-Gendy, Zeinab A.
El-Marasy, Salma A.
Ahmed, Rania F.
El-Batran, Seham A.
Abd El-Rahman, Sahar S.
Ramadan, A.
Youssef, S.A.H.
author_facet El-Gendy, Zeinab A.
El-Marasy, Salma A.
Ahmed, Rania F.
El-Batran, Seham A.
Abd El-Rahman, Sahar S.
Ramadan, A.
Youssef, S.A.H.
author_sort El-Gendy, Zeinab A.
collection PubMed
description Fibrosis represents a common outcome of almost all chronic liver diseases and leads to an impairment of liver function that requires medical intervention. The current study aimed to evaluate the potential anti-fibrotic effect of Saccharomyces cervisciae cell wall extract (SCCWE) against thioacetamide (TAA)-induced liver fibrosis in rats (200mg/kg b.w. i.p. twice weekly for 6 weeks) using Ursodeoxycholic acid (UDCA) as a reference anti-fibrotic product. SCCWE at two doses (50 and 100 mg/kg) significantly ameliorated the rise in serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), gamma glutamide transferase (GGT) activities, total bilirubin and direct bilirubin, increased total protein and albumin. SCCWE significantly reduced glutathione depletion (GSH), Nitric oxide (NOx) and malondialdehyde (MDA), thioredoxin (Trx) contents and elevated nuclear factor erythroid 2–related factor 2 (Nrf-2) content. Its anti-inflammatory effects were confirmed by observing a decrease in nuclear factor-κB (NF- κβ), interleukin-1b (IL-1β) and inducible nitric oxide synthase (iNOS) content. The anti-fibrotic effects of SCCWE were explored by assessing fibrosis related markers as it significantly reduced transform growth factor-β (TGF-β) and autotaxin (ATX) contents. Administration of SCCWE significantly decreased matrix metalloproteinase-3 and 9 (MMP-3 and -9). Furthermore, it also decreased alpha smooth muscle actin (α-SMA) and caspase-3 as assessed immunohistochemically those results were similar to that of the standard drug UDCA. This study shows that SCCWE protects against TAA-induced liver fibrosis in rats, through attenuating oxidative stress, and inflammation, ameliorating MMPs, combating apoptosis and thereby fibrotic biomarkers in addition to improving histopathological changes.
format Online
Article
Text
id pubmed-8203708
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-82037082021-06-21 Hepatoprotective effect of Saccharomyces Cervisciae Cell Wall Extract against thioacetamide-induced liver fibrosis in rats El-Gendy, Zeinab A. El-Marasy, Salma A. Ahmed, Rania F. El-Batran, Seham A. Abd El-Rahman, Sahar S. Ramadan, A. Youssef, S.A.H. Heliyon Research Article Fibrosis represents a common outcome of almost all chronic liver diseases and leads to an impairment of liver function that requires medical intervention. The current study aimed to evaluate the potential anti-fibrotic effect of Saccharomyces cervisciae cell wall extract (SCCWE) against thioacetamide (TAA)-induced liver fibrosis in rats (200mg/kg b.w. i.p. twice weekly for 6 weeks) using Ursodeoxycholic acid (UDCA) as a reference anti-fibrotic product. SCCWE at two doses (50 and 100 mg/kg) significantly ameliorated the rise in serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), gamma glutamide transferase (GGT) activities, total bilirubin and direct bilirubin, increased total protein and albumin. SCCWE significantly reduced glutathione depletion (GSH), Nitric oxide (NOx) and malondialdehyde (MDA), thioredoxin (Trx) contents and elevated nuclear factor erythroid 2–related factor 2 (Nrf-2) content. Its anti-inflammatory effects were confirmed by observing a decrease in nuclear factor-κB (NF- κβ), interleukin-1b (IL-1β) and inducible nitric oxide synthase (iNOS) content. The anti-fibrotic effects of SCCWE were explored by assessing fibrosis related markers as it significantly reduced transform growth factor-β (TGF-β) and autotaxin (ATX) contents. Administration of SCCWE significantly decreased matrix metalloproteinase-3 and 9 (MMP-3 and -9). Furthermore, it also decreased alpha smooth muscle actin (α-SMA) and caspase-3 as assessed immunohistochemically those results were similar to that of the standard drug UDCA. This study shows that SCCWE protects against TAA-induced liver fibrosis in rats, through attenuating oxidative stress, and inflammation, ameliorating MMPs, combating apoptosis and thereby fibrotic biomarkers in addition to improving histopathological changes. Elsevier 2021-05-27 /pmc/articles/PMC8203708/ /pubmed/34159266 http://dx.doi.org/10.1016/j.heliyon.2021.e07159 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Article
El-Gendy, Zeinab A.
El-Marasy, Salma A.
Ahmed, Rania F.
El-Batran, Seham A.
Abd El-Rahman, Sahar S.
Ramadan, A.
Youssef, S.A.H.
Hepatoprotective effect of Saccharomyces Cervisciae Cell Wall Extract against thioacetamide-induced liver fibrosis in rats
title Hepatoprotective effect of Saccharomyces Cervisciae Cell Wall Extract against thioacetamide-induced liver fibrosis in rats
title_full Hepatoprotective effect of Saccharomyces Cervisciae Cell Wall Extract against thioacetamide-induced liver fibrosis in rats
title_fullStr Hepatoprotective effect of Saccharomyces Cervisciae Cell Wall Extract against thioacetamide-induced liver fibrosis in rats
title_full_unstemmed Hepatoprotective effect of Saccharomyces Cervisciae Cell Wall Extract against thioacetamide-induced liver fibrosis in rats
title_short Hepatoprotective effect of Saccharomyces Cervisciae Cell Wall Extract against thioacetamide-induced liver fibrosis in rats
title_sort hepatoprotective effect of saccharomyces cervisciae cell wall extract against thioacetamide-induced liver fibrosis in rats
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8203708/
https://www.ncbi.nlm.nih.gov/pubmed/34159266
http://dx.doi.org/10.1016/j.heliyon.2021.e07159
work_keys_str_mv AT elgendyzeinaba hepatoprotectiveeffectofsaccharomycescervisciaecellwallextractagainstthioacetamideinducedliverfibrosisinrats
AT elmarasysalmaa hepatoprotectiveeffectofsaccharomycescervisciaecellwallextractagainstthioacetamideinducedliverfibrosisinrats
AT ahmedraniaf hepatoprotectiveeffectofsaccharomycescervisciaecellwallextractagainstthioacetamideinducedliverfibrosisinrats
AT elbatransehama hepatoprotectiveeffectofsaccharomycescervisciaecellwallextractagainstthioacetamideinducedliverfibrosisinrats
AT abdelrahmansahars hepatoprotectiveeffectofsaccharomycescervisciaecellwallextractagainstthioacetamideinducedliverfibrosisinrats
AT ramadana hepatoprotectiveeffectofsaccharomycescervisciaecellwallextractagainstthioacetamideinducedliverfibrosisinrats
AT youssefsah hepatoprotectiveeffectofsaccharomycescervisciaecellwallextractagainstthioacetamideinducedliverfibrosisinrats